Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)
Adult
Blood Glucose
Adolescent
type 1 diabetes
Sustainable Development Goals
Diabetes Mellitus, Type 1/drug therapy
610
physical activity
610 Medicine & health
Position statement
Glycemic Control
Adolescents
796
03 medical and health sciences
0302 clinical medicine
children
Exercise/physiology
adults
Adults
Humans
Hypoglycemic Agents
Insulin
adolescents
Child
Children
Continuous glucose monitoring
Exercise
Quality Of Life
SDG 3
Blood Glucose/metabolism
exercise
CGM
Physical activity
Blood Glucose Self-Monitoring
position statement
Diabetes Mellitus, Type 1/physiopathology
Hypoglycemic Agents/administration & dosage
3. Good health
Type 1 diabetes
Diabetes Mellitus, Type 1
quality of life
Ispad Guidelines
Quality of Life
continuous glucose monitoring
Glycemic Control/methods
Insulin/administration & dosage
DOI:
10.1007/s00125-020-05263-9
Publication Date:
2020-10-12T23:02:51Z
AUTHORS (30)
ABSTRACT
Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (ie, before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (106)
CITATIONS (130)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....